Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOSSOM: OCF001 Intravaginal Gel in Women With Acute Vulvovaginal Candidiasis
NCT07521137Phase 2Recruiting
- Sponsor
- Sano Chemicals
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Modality
- Cyclic Peptides, Peptide Conjugates, Antimicrobial Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of occidiofungin in vulvovaginal candidiasis (VVC), sponsored by Sano Chemicals. Started Jun 2026; status: recruiting.
02
Drugs
occidiofungin
03
Conditions
vulvovaginal candidiasis (VVC)
Beyond the preview
Go deeper on NCT07521137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07521137.